140 related articles for article (PubMed ID: 22340901)
1. Quality improvement in travel medicine: a programme for yellow fever vaccination centres in England, Wales and Northern Ireland.
Boddington NL; Simons H; Launders N; Hill DR
Qual Prim Care; 2011; 19(6):391-8. PubMed ID: 22340901
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of travel medicine practice by yellow fever vaccination centers in England, Wales, and Northern Ireland.
Boddington NL; Simons H; Launders N; Gawthrop M; Stillwell A; Wong C; Mathewson J; Hill DR
J Travel Med; 2012; 19(2):84-91. PubMed ID: 22414032
[TBL] [Abstract][Full Text] [Related]
3. Analysis of yellow fever vaccination practice in England.
Bryant N; Tucker R; Simons H; Bailey S; Mathewson J; Lea G; Hill DR
J Travel Med; 2008; 15(5):287-93. PubMed ID: 19006500
[TBL] [Abstract][Full Text] [Related]
4. Standards of yellow fever vaccination and travel medicine practice in the Republic of Ireland: A questionnaire-based evaluation.
Noone P; Hamza M; Tang J; Flaherty G
Travel Med Infect Dis; 2015; 13(5):409-14. PubMed ID: 26148651
[TBL] [Abstract][Full Text] [Related]
5. National review of reported Yellow fever vaccine incidents in the UK.
Gnanadurai R; Campos-Matos I; Kanagarajah S; Geary K; Simons H; Patel D
Travel Med Infect Dis; 2022; 47():102289. PubMed ID: 35227862
[TBL] [Abstract][Full Text] [Related]
6. Access to yellow fever travel vaccination centres in England, Wales, and Northern Ireland: A geographical study.
Petersen J; Simons H; Patel D
Travel Med Infect Dis; 2017; 18():24-29. PubMed ID: 28698027
[TBL] [Abstract][Full Text] [Related]
7. Preferences and decision needs of Boston-area travelers to countries with risk of Yellow fever virus transmission: implications for health care providers.
Lown BA; Chen LH; Han PV; Jentes ES; Wilson ME; Benoit CM; Avery KA; Ooi W; Hamer DH; Barnett ED;
J Travel Med; 2014; 21(4):266-71. PubMed ID: 24734961
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of yellow fever vaccination centers in Canada.
Labelle C; Macpherson DW
J Travel Med; 2005; 12(4):180-3. PubMed ID: 16086891
[TBL] [Abstract][Full Text] [Related]
9. No booster dose for yellow fever vaccination: what are the consequences for the activity of vaccination in travel clinics?
Wyplosz B; Leroy JP; Derradji O; Consigny PH
J Travel Med; 2015; 22(2):140-1. PubMed ID: 25384441
[TBL] [Abstract][Full Text] [Related]
10. Linking yellow fever vaccinator approval and renewal with training in travel medicine in New Zealand.
O'Brien B; Leggat PA
Travel Med Infect Dis; 2010 Jul; 8(4):210-2. PubMed ID: 20970723
[TBL] [Abstract][Full Text] [Related]
11. Yellow fever vaccination: is one dose always enough?
Patel D; Simons H
Travel Med Infect Dis; 2013; 11(5):266-73. PubMed ID: 24074827
[TBL] [Abstract][Full Text] [Related]
12. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Staples JE; Gershman M; Fischer M;
MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
[TBL] [Abstract][Full Text] [Related]
13. Yellow fever vaccine: an effective vaccine for travelers.
Verma R; Khanna P; Chawla S
Hum Vaccin Immunother; 2014; 10(1):126-8. PubMed ID: 24056028
[TBL] [Abstract][Full Text] [Related]
14. Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011.
Jentes ES; Han P; Gershman MD; Rao SR; LaRocque RC; Staples JE; Ryan ET; The Global TravEpiNet Consortium
Am J Trop Med Hyg; 2013 May; 88(5):954-961. PubMed ID: 23458961
[TBL] [Abstract][Full Text] [Related]
15. Unpredictable checks of yellow fever vaccination certificates upon arrival in Tanzania.
Schönenberger S; Hatz C; Bühler S
J Travel Med; 2016 May; 23(5):. PubMed ID: 27296582
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of adverse events after yellow fever vaccination between elderly and non-elderly travellers: questionnaire survey in Japan over a 1-year period.
Tanizaki R; Ujiie M; Hori N; Kanagawa S; Kutsuna S; Takeshita N; Hayakawa K; Kato Y; Ohmagari N
J Travel Med; 2016 Mar; 23(3):. PubMed ID: 27021495
[TBL] [Abstract][Full Text] [Related]
17. Yellow fever vaccination coverage among children in Brazilian capitals.
Veras MA; Flannery B; de Moraes JC; da Silva Teixeira AM; Luna EJ;
Vaccine; 2010 Sep; 28(39):6478-82. PubMed ID: 20674878
[TBL] [Abstract][Full Text] [Related]
18. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
[TBL] [Abstract][Full Text] [Related]
19. Importation of yellow fever into China: assessing travel patterns.
Wilder-Smith A; Leong WY
J Travel Med; 2017 Jul; 24(4):. PubMed ID: 28426111
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.
Alberer M; Burchard G; Jelinek T; Reisinger E; Beran J; Hlavata LC; Forleo-Neto E; Dagnew AF; Arora AK
J Travel Med; 2015; 22(1):48-56. PubMed ID: 25308927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
